The Latest Breaking News from Myriad Genetics

Myriad Genetics Stock: A Deep Dive Into Analyst Perspectives (4 Ratings)

In the preceding three months, 4 analysts have released ratings for Myriad Genetics (NASDAQ:MYGN), presenting a wide array of perspectives from bullish to bearish.

Benzinga · Dec 9, 2024

Recap: Myriad Genetics Q1 Earnings

  Myriad Genetics (NASDAQ:MYGN) reported its Q1 earnings results on Thursday, May 5, 2022 at 07:05 AM. Here's what investors need to know about the announcement.

Benzinga · May 5, 2022

Myriad Genetics's Earnings: A Preview

Myriad Genetics (NASDAQ:MYGN) is set to give its latest quarterly earnings report on Thursday, 2022-05-05. Here's what investors need to know before the announcement. Analysts estimate that Myriad Genetics will report an earnings per share (EPS) of $-0.07.

Benzinga · May 4, 2022